Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The HORIZONS-AMI trial
Authors:
- Bernhard WitzenbichlerBWBernhard Witzenbichler
- Giulio GuagliumiGGGiulio Guagliumi
- Jan Z. PerugaJPJan Z. Peruga
- Bruce R. BrodieBBBruce R. Brodie
- Ke XuKXKe Xu
- Martin FahyMFMartin Fahy
- Roxana MehranRMRoxana Mehran
- Gregg W. StoneGSGregg W. Stone
- 1 September 2013
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 167 (6) , 2572-2579
Abstract
No abstract availableKeywords
Funding Information
- Medicines Company
- Cardiovascular Research Foundation
- Boston Scientific Corporation
This publication has 29 references indexed in Scilit:
- Glucose-Lowering Targets for Patients With Cardiovascular DiseaseCirculation, 2010
- High cortisol levels in hyperglycaemic myocardial infarct patients signify stress hyperglycaemia and predict subsequent normalization of glucose toleranceClinical Endocrinology, 2010
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)Circulation, 2009
- GlucoseCirculation, 2008
- Association of Blood Glucose With Angiographic and Clinical Outcomes Among Patients With ST-Segment Elevation Myocardial Infarction (from the CLARITY-TIMI-28 Study)The American Journal of Cardiology, 2008
- Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial InfarctionCirculation, 2005
- Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarctionJACC, 2005
- Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidityEuropean Heart Journal, 2005
- Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarctionJACC, 2003
- Nitric oxide release accounts for insulin's vascular effects in humans.Journal of Clinical Investigation, 1994